You Position: Home > Paper
Treatment of dyslipidemia in diabetes
( views:483, downloads:216 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF DIABETES
- Issue:
- 1
- DOI:
- 10.3321/j.issn:1006-6187.2007.01.002
- Key Word:
- 血脂异常;糖尿病;降血脂药;血脂康
Abstract： 有93%的糖尿病患者伴有心血管病,约80%伴有动脉粥样硬化,其中75%死于冠心病.血脂异常是动脉粥样硬化和冠心病的一个重要危险因素,因此糖尿病患者血脂异常的治疗是一个应十分重视的问题.本文简要介绍了糖尿病患者血脂异常的特点, 糖尿病患者血脂异常的治疗对临床预后的影响及糖尿病患者血脂异常的药物治疗.
- [1]Goldberg,RB,Mellies,MJ,Sacks,FM,etc.Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigat[J].1998,98(23).
- [2]J, Shepherd,S M, Cobbe,I, Ford,etc.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.[J].1995,333.
- [3]UK Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2\u00a0diabetes: UKPDS 38[J].1998.
- [4]d'Emden M,Whiting M,Barter P,etc.Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.[J].2005,366(9500).
- [5]陆宗良,杜保民,陈祚,等.中国冠心病二级预防研究-对合并糖尿病患者的干预结果分析[J].2005,(12).
- [6].Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels.[J].1998,339(19).
- [7]Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J].1994,344(8934).